Additionally, we noted that MAFLD in patients with IBD was associated with shortened IBD duration, a higher Hb, an elevated GPT level, a decreased eGFR, an elevated γ-GT, and significant fibrosis. The gene discussed is GSTM1; the disease is inflammatory bowel disease.